The Anti-CA9 (Girentuximab) Biosimilar MAb (HDBS0040) offered by Assay Genie is a monoclonal antibody specifically designed for research involving carbonic anhydrase 9 (CA9), a cell surface protein that is highly expressed in various types of cancer, including renal cell carcinoma. This biosimilar MAb is a cost-effective alternative to the original Girentuximab antibody, providing researchers with a reliable tool for studying the role of CA9 in cancer progression and therapeutic targeting.The Anti-CA9 (Girentuximab) Biosimilar MAb (HDBS0040) is produced using state-of-the-art recombinant technology, ensuring high specificity and sensitivity in detecting CA9 in tissue samples and cell lines.
With its ability to bind specifically to CA9, this antibody is ideal for applications such as immunohistochemistry and flow cytometry, allowing for detailed analysis of CA9 expression patterns in different cancer types.By using the Anti-CA9 (Girentuximab) Biosimilar MAb (HDBS0040) in their research, scientists can gain valuable insights into the role of CA9 in tumor growth, metastasis, and response to therapy. Furthermore, this antibody can serve as a valuable tool for the development of novel diagnostic and therapeutic strategies targeting CA9-expressing tumors, ultimately contributing to advancements in cancer treatment.
Product Name:
Girentuximab (Anti-CA9) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0040
Target:
CA9
Host Species:
Chimeric
Reactivity:
Human
Recommended Dilution:
ELISA 1:5000-10000; Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
WX-G250, cG250
Description:
Anti-CA9 (girentuximab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA, Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
